Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
PrOspective Non-interventional Study in Patients With Locally Advanced or Metastatic TRK Fusion Cancer Treated With Larotrectinib
Protocol ID
ON TRK
Disease (Sub Disease)
Solid tumours (NTRK Gene Fusion)
Location
NSW, WA
Sponsor
Bayer
Trial Status
Open
Sites
The Children's Hospital at Westmead
Perth Children's Hospital
Study Type
Observational
Phase
Not applicable
Age Eligibility
no limits
International registry ID's
NCT04142437
Back to Registry
Study Title PrOspective Non-interventional Study in Patients With Locally Advanced or Metastatic TRK Fusion Cancer Treated With Larotrectinib
Protocol ID ON TRK
Disease (Sub Disease) Solid tumours (NTRK Gene Fusion)
Location NSW / WA
Sponsor Bayer
Links https://clinicaltrials.gov/ct2/show/NCT04142437
Trial Status Open
Trial Open Date 03/04/2020
Sites The Children's Hospital at Westmead / Perth Children's Hospital
Study Type Observational
Phase Not applicable
Age Eligibility no limits
International registry ID's NCT04142437